Sweden· SE-19860613000150
Sendoxan 50 mg Dragerad tablett
A medicinal product containing cyclophosphamide, registered in Sweden by Baxter Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Cyclophosphamide
- Manufacturer
- Baxter Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19860613000150
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cyclophosphamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandEndoxanBaxter Polska Sp. z o.o.
- United StatesCyclophosphamideCivica, Inc.
- United KingdomCyclophosphamide 1000mg/250ml in Sodium chloride 0.9% infusion bagsSpecial Order
- CzechiaCYCLOPHOSPHAMIDE ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- BelgiumCyclofosfamide Accord 1000 mgAccord Healthcare
- NetherlandsCyclofosfamide Accord 1000 mg, poeder voor oplossing voor injectie / infusieAccord Healthcare B.V.
- SpainCICLOFOSFAMIDA ACCORD 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSIÓN EFGAccord Healthcare S.L.U.
- FinlandCyclophosphamide AccordAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cyclophosphamid Sandoz, Endoxan
- Belgium · Cyclofosfamide Accord, Cyclophosphamide Hikma
- Bulgaria · Cyclophosphamide Sandoz, Ендоксан
- Cyprus · Cyclophosphamide Accord, Endoxan
- Czechia · Cyclophosphamide Accord, Endoxan
- Germany · Cyclophosphamid Accord, Cyclophosphamid Beta
- Denmark · Cyclophosphamide Accord, Cyclophosphamide Sandoz
- Estonia · Cyclophosphamide Accord, Endoxan
- Spain · Ciclofosfamida Accord, Ciclofosfamida Dr. Reddy
- Finland · Cyclophosphamide Accord, Sendoxan
- France · Cyclophosphamide Accord, Cyclophosphamide Reddy Pharma
- United Kingdom (Northern Ireland) · Cyclophosphamide Accord Healthcare, Cyclophosphamide Accord-Uk
- Greece · Endoxan
- Croatia · Ciklofosfamid Accord, Endoxan
- Hungary · Endoxan
- Ireland · Cyclophosphamide Monohydrate Seacross, Endoxana
- Iceland · Sendoxan
- Italy · Ciclofosfamide Accord, Cyclophosphamide Monohydrate Seacross
- Lithuania · Cyclophosphamide Accord Healthcare, Endoxan
- Luxembourg · Endoxan
- Latvia · Cyclophosphamide Accord, Endoxan
- Malta · Endoxana, Endoxana Injection
- Netherlands · Cyclofosfamide Accord, Cyclofosfamide Hikma
- Norway · Cyclophosphamide Accord, Sendoxan
- Poland · Cyclophosphamide Accord, Cyclophosphamide Sandoz
- Portugal · Ciclofosfamida Accord, Ciclofosfamida Hikma
- Romania · Ciclofosfamidă Accord, Ciclofosfamidă Dr. Reddy’s
- Slovenia · Endoxan
- Slovakia · Endoxan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbbd685e-68a9-45d2-9d47-17ebe386bed2 GET /v1/drugs/cbbd685e-68a9-45d2-9d47-17ebe386bed2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "19860613000150",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19860613000150",
"product_doc_link": "https://docetp.mpa.se/LMF/Sendoxan%20coated%20tablet%20SmPC_09001bee807a6de9.pdf"
}See everything about cyclophosphamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.